SETStoneweg Europe Stapled Trust

🇸🇬 Singapur Borsası
1.46
SGD
Analysis Scores
Lothien Robustness Score?
44/100
Moderate
Neden bu skor?
Damodaran ?
19/100
ROIC banka/finans için tanımsız — mevduat/prim fonlaması borç değil hammaddedir; değerleme öz-sermaye (P/DD) tabanlı yapılır
Dalio Risk ?
77/100
Piotroski ?
8/9
Strong
Graham ?
S$3.8
Ucuz
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
59/100
Lothien Sağlamlık: Orta (59/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Nötr | Uzun Vade: Nötr | Pozitif: 4 | Negatif: 2 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte S$28M net kâr açıklandı. Şirket kârlı.
Kâr Stabil
Net kâr bir önceki çeyreğe göre fazla değişmedi (%+0.0). İstikrarlı seyir.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+122.8 arttı. Büyüme trendi sağlıklı.
Yüksek Net Kâr Marjı
Net kâr marjı %36.8. Her 100S$ satıştan 37S$ kâr kalıyor.
Orta Seviye Borç
Net borç/özkaynak 0.73x. Yönetilebilir seviyede ama takip edilmeli.
Yüksek EV/EBITDA
EV/EBITDA: 19.7. Pahalı değerleme.
Düşük ROE
ROE: %3.4. Sermaye getirisi yetersiz — enflasyonun altında.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+28.0 artabilir (S$28M → S$36M).

Data date 2026-10-23 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-23
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Orta
252 days
Annual Volatility ?
%20.4
VaR 95% ?
%2.12
daily max loss
VaR 99% ?
%2.99
daily max loss
CVaR 95% ?
%2.84
expected loss (tail)
Max Drawdown ?
%17.4
20.01.2026 → 21.10.2026
Skewness ?
-0.13
Parametrik%2.12
Historik%1.98
Cornish-Fisher%2.16
Return Distribution
Valuation
Potential?
-39.0%
DCF Value ?
0.35
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/6
Toplam borç: 1.5B SGD
Net borç: 1.4B SGD
Borç/Özkaynak oranı: 0.89x
Cari oran: 1.04x — yeterli likidite
Nakit ve benzerleri: 64.7M SGD
Ödenmiş sermaye: 1.7B SGD
Net işletme sermayesi pozitif: 4.4M SGD
Son 6 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-5.3 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 1.54 SGD
Sabit varlık ağırlıklı bilanço: Dönen varlıklar %3
Fundamental & Technical Analysis
Profitability
Net Profit Margin %36.8
Net profit margin %36.8 — very strong. Compared to previous quarter +0.0 point increase.
ROE - Return on Equity (TTM) %3.3
ROE %3.3 — low return on equity.
EBITDA Margin %63.5
EBITDA margin %63.5 — operationally very efficient.
Gross Profit Margin %59.9
Gross profit per revenue %59.9. Strong pricing power.
Free Cash Flow Margin (TTM) %19.4
TTM Free Cash Flow is %19.4'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio 21.4x Sector: 10.5x
F/K 21.4x — sector median's (10.5x) %104 above. Expensive zone.
P/B Ratio 1.47x Sector: 0.88x
PD/DD 1.47x — sector median's %67 above. Expensive book value.
EV/EBITDA 19.7x Sector: 9.2x
EV/EBITDA 19.7x — sector median's (9.2x) %115 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 1.04x
Current ratio 1.04x — borderline, attention required.
Net Debt / EBITDA 7.6x
Net Debt/EBITDA 7.6x — excessive leverage. Fragile debt profile.
Debt / Equity 0.89x
Debt/Equity 0.89x — moderate financial leverage.
Interest Coverage 4.9x
Interest coverage 4.9x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY) %+0.8
Revenue YoY %0.8 grew — positive but slow growth.
Net Profit Growth (YoY) %+122.8
Net profit YoY %122.8 increased (2025/12) — extraordinary profit growth.
Score Explanations
Lothien Robustness
44/100
Moderate robustness (44/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-39.0%
Minus %39.0 expected value (0.89) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 0.77 | P/B target: 0.90 | EV/EBITDA target: 0.68 | DCF target: 0.36
Damodaran Valuation
19/100
Very Weak
Dalio Risk Analysis
77/100
Low debt risk (77/100). Interest coverage ratio 4.9x — acceptable. Debt/EBITDA 7.6x — high debt burden.
Leverage: 50/100 | Debt Service: 69/100 | Quality: 87/100
DCF Discounted Cash Flow
0.35
DCF (0.35) current price %76.3 below — cash flows do not support current price.
Current price: 1.46
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
8/9
Strong Piotroski F-Score (8/9). Profitability, leverage and operational efficiency criteria are largely met.
Strong
Graham Intrinsic Value
S$3.8
Graham intrinsic value: S$3.8. Ucuz
Cheap
⚖️ Sector Comparison
P/E Ratio
21.4x vs 10.5x
Sector median's %104 above — expensive
P/B Ratio
1.47x vs 0.88x
Compared to sector %67 more expensive (by book value)
EV/EBITDA
19.7x vs 9.2x
Compared to sector %115 higher EV/EBITDA
Net Profit Margin (TTM)
%36.8 vs %63.5 EBITDA margin
TTM net profit margin %36.8
TRAMA-99 Trend — Downtrend
Price (1.46), TRAMA-99 line's %5.3 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 1.46
TRAMA: 1.54
Difference: %-5.3
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
SET — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.